Leadership

TransCode's senior leadership team combines decades of oncology drug discovery and development expertise,  to add both scientific insight and valuable strategic perspective to address cancer and create a sustainable commercialization product pipeline. 

Management Team

Philippe Calais, PhD
​Executive Chairman
​CEO

Tom Fitzgerald MBA,
CFO

Susan Duggan, RN, MBA
Sr. VP of Operations

Michel Janicot, Ph.D, Consulting Senior Development Officer​

Zdravka Medarova, PhD
Cofounder/Chief Scientific Officer

Tania Montgomery
Business Development

Ram Bhat, PhD
​Sr. Director CMC
In Memoriam 1961-2023

 Neil Robertson, PhD
Consulting Senior Scientist

---

Board of Directors

Philippe Calais, PhD
​CEO, Executive Chairman

Magda Marquet, PhD
​Director

Erik Manting, PhD
​Director

Tom Fitzgerald
CFO, Director

Elizabeth A. Czerepak
CFO, Director

Jack E. Stover
Director

---

Advisory Board

Anna Moore, PhD
​Cofounder

Keith Flaherty, MD

Phillip D. Zamore, PhD
​

Frank J.Slack, PhD
​

Lubomir Nechev, PhD
​

Dejan Juric, MD

---

---